Biopharmadive.com

Bio Pharma Dive. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

Today's Biopharmadive.com headlines: Observe fresh posts and updates on Bio Pharma Dive. It is pretty active and updates frequently with 80+ articles published this month alone (they might potentially reach about 155K visitors within the said period of time). It is generally safe for browsing, so you may click any item to proceed to the site.

News, stories and media buzz related to Bio Pharma Dive

Subscribe to related news

Big Pharma quietly enlists leading professors to justify $1,000-per-day drugs
via patriotrising

Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs such as Medicare and Medicaid, to cover the costs. That isn’t an...
InPlay from Briefing.com
via whotrades.olanola

------ Major European indices trade lower across the board with Germany's DAX (-2.0%) trailing the region. Elsewhere, European Central Bank member Benoit Coeure said that debt relief for Greece is no longer a subject of debate with bailout negotiations...
Big Pharma Recruiting Professors to Justify $1,000-Per-Day Pills
via alternet

Click here for reuse options! In scholarly articles, blogs and conferences, professors lend their prestige to the lobbying blitz, without always disclosing their corporate ties. Over the last three years, pharmaceutical companies have mounted a public...
Big Pharma Quietly Enlists Leading Professors to Justify $1,000-Per-Day Drugs
via propublica

by Annie Waldman This story was co-published with Consumer Reports. Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs...
Big Pharma Quietly Enlists Leading Professors To Justify $1,000-Per-Day Drugs
via beachwoodreporter

Over the last three years, pharmaceutical companies have mounted a public relations blitz to tout new cures for the hepatitis C virus and persuade insurers, including government programs such as Medicare and Medicaid, to cover the costs. That isn't...

Biopharmadive.com popular pages

Biotech and Pharma Industry News | BioPharma Dive

BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regula...
FDA clears third antibacterial for skin infections this year | BioPharma Dive

BioPharma

About | BioPharma Dive

BioPharma Dive Our mission is to provide busy professionals like you with a bird's-eye-view of the BioPharma industry in 60 seconds. We cover industry news and provide original analysis. Throughout th...